Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eisuke Mekada

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
Biochemical and Biophysical Research Communications|November 21, 2007
Validation of HB-EGF and amphiregulin as targets for human cancer therapyFusanori Yotsumoto, Hiroshi Yagi, Satoshi O Suzuki, et al.
Molecular Reproduction and Development|February 10, 2007
Possible involvement of CD81 in acrosome reaction of sperm in miceMaya Tanigawa, Kiyoko Miyamoto, Satoshi Kobayashi, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 8, 2007
Maternal heparin-binding-EGF deficiency limits pregnancy success in miceHuirong Xie, Haibin Wang, Susanne Tranguch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2005
Clinical significance of heparin-binding epidermal growth factor-like growth factor and a disintegrin and metalloprotease 17 expression in human ovarian cancerYoshihiro Tanaka, Shingo Miyamoto, Satoshi O Suzuki, et al.
Cancer Research|October 20, 2011
HB-EGF and PDGF mediate reciprocal interactions of carcinoma cells with cancer-associated fibroblasts to support progression of uterine cervical cancersTakuya Murata, Hiroto Mizushima, Ichino Chinen, et al.
Anticancer Research|July 31, 2014
Pre-clinical study of BK-UM, a novel inhibitor of HB-EGF, for ovarian cancer therapySung Ouk Nam, Fusanori Yotsumoto, Kohei Miyata, et al.
Journal of Cell Science|June 1, 2005
Heparin-binding EGF-like growth factor accelerates keratinocyte migration and skin wound healingYuji Shirakata, Rina Kimura, Daisuke Nanba, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|November 2, 2020
Identification of GII.14[P7] norovirus and its genomic mutations from a case of long-term infection in a post-symptomatic individualNutthawan Nonthabenjawan, Patcharaporn Boonyos, Benjarat Phattanawiboon, et al.
Cancer Research|August 18, 2004
Heparin-binding EGF-like growth factor is a promising target for ovarian cancer therapyShingo Miyamoto, Michinari Hirata, Ayano Yamazaki, et al.
Plos One|July 24, 2020
Norovirus transmission mediated by asymptomatic family members in householdsBenjarat Phattanawiboon, Nutthawan Nonthabenjawan, Patcharaporn Boonyos, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Biochemical and Biophysical Research Communications|November 21, 2007
Validation of HB-EGF and amphiregulin as targets for human cancer therapyFusanori Yotsumoto, Hiroshi Yagi, Satoshi O Suzuki, et al.
Molecular Reproduction and Development|February 10, 2007
Possible involvement of CD81 in acrosome reaction of sperm in miceMaya Tanigawa, Kiyoko Miyamoto, Satoshi Kobayashi, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 8, 2007
Maternal heparin-binding-EGF deficiency limits pregnancy success in miceHuirong Xie, Haibin Wang, Susanne Tranguch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2005
Clinical significance of heparin-binding epidermal growth factor-like growth factor and a disintegrin and metalloprotease 17 expression in human ovarian cancerYoshihiro Tanaka, Shingo Miyamoto, Satoshi O Suzuki, et al.
Cancer Research|October 20, 2011
HB-EGF and PDGF mediate reciprocal interactions of carcinoma cells with cancer-associated fibroblasts to support progression of uterine cervical cancersTakuya Murata, Hiroto Mizushima, Ichino Chinen, et al.
Anticancer Research|July 31, 2014
Pre-clinical study of BK-UM, a novel inhibitor of HB-EGF, for ovarian cancer therapySung Ouk Nam, Fusanori Yotsumoto, Kohei Miyata, et al.
Journal of Cell Science|June 1, 2005
Heparin-binding EGF-like growth factor accelerates keratinocyte migration and skin wound healingYuji Shirakata, Rina Kimura, Daisuke Nanba, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|November 2, 2020
Identification of GII.14[P7] norovirus and its genomic mutations from a case of long-term infection in a post-symptomatic individualNutthawan Nonthabenjawan, Patcharaporn Boonyos, Benjarat Phattanawiboon, et al.
Cancer Research|August 18, 2004
Heparin-binding EGF-like growth factor is a promising target for ovarian cancer therapyShingo Miyamoto, Michinari Hirata, Ayano Yamazaki, et al.
Plos One|July 24, 2020
Norovirus transmission mediated by asymptomatic family members in householdsBenjarat Phattanawiboon, Nutthawan Nonthabenjawan, Patcharaporn Boonyos, et al.
Pageof 7